ATLAS fair value
A$0.379
Above fair value · 87% premium
Monash Ivf share price today, ATLAS forecast and fair value
Healthcare · Diagnostics & Research · Australian Securities Exchange · Australia
Prices as of Oct 27, 2026 · AUD
A$0.379
Above fair value · 87% premium
50%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Monash Ivf's fair value at about A$0.379 per share (reasonable range: A$0.244 to A$0.589). At A$0.710, the stock trades 87% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Monash Ivf a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between A$0.663 and A$0.759; in 9 out of 10, between A$0.588 and A$0.857. Estimated annual volatility is 35%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Monash Ivf sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks MVF.AU has traded between A$0.575 and A$0.895. Today it is 20.7% below that high and 23% above its low.
On the business: net margin is 2.8%; it trades at 36.5 times earnings.
Its beta is 0.34: it tends to move less than the market.
Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services.
Want to see everything about Monash Ivf?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About A$0.379 per share according to ATLAS (reasonable range: A$0.244 to A$0.589). With the stock at A$0.710, it is 87% above it.
50%: close to a coin flip. In half of the simulated outcomes, MVF.AU ends the month between A$0.663 and A$0.759.
Monash Ivf's market capitalization is A$280M. Its price-to-earnings (P/E) ratio is 36.5: you pay A$36.5 for each A$1.00 of yearly earnings.
Yes. MVF.AU's current dividend yield is 3.52% at today's price (A$0.710).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy